The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lund, F. E.
Right arrow Articles by Howard, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lund, F. E.
Right arrow Articles by Howard, M. C.

The Journal of Immunology, Vol 157, Issue 4 1455-1467, Copyright © 1996 by American Association of Immunologists


ARTICLES

Signaling through CD38 augments B cell antigen receptor (BCR) responses and is dependent on BCR expression

FE Lund, N Yu, KM Kim, M Reth and MC Howard
DNAX Research Institute, Palo Alto, CA 94304, USA.

mAbs directed against the ectoenzyme CD38 will induce B cell proliferation in normal resting B lymphocytes, but cannot induce proliferation in B cells that are unresponsive to B cell Ag receptor (BCR) cross-linking. Using the CD38- murine B cell line A20 we have examined the relationship between CD38- and BCR-mediated signaling after transfection of wild-type or mutant CD38 molecules. Although association between CD38 and the BCR was not detectable, co-cross- linking of CD38 and the BCR gave rise to a synergistic response, and expression of CD38 lowered the threshold for BCR-induced responses. Generation of Ig loss variant clones established that coexpression of the BCR was required for CD38-mediated signal transduction. The cytoplasmic tail of Ig alpha or Ig beta rescued CD 38 responsiveness in the CD38+Ig- cells provided that the chimeric molecules were coligated with CD38. Separate experiments indicated that the cytoplasmic tail of CD38 is not required for CD38 signaling. The anti-CD38-induced response was dependent on the influx of extracellular calcium but was not accompanied by detectable tyrosine phosphorylation of any cellular proteins. Together, these data demonstrate that the CD38 molecule can influence BCR-induced responses and that CD38 signaling is dependent on the BCR complex, perhaps to utilize a functional cytoplasmic tail(s) for intracellular signaling.


This article has been cited by other articles:


Home page
Physiol. Rev.Home page
F. Malavasi, S. Deaglio, A. Funaro, E. Ferrero, A. L. Horenstein, E. Ortolan, T. Vaisitti, and S. Aydin
Evolution and Function of the ADP Ribosyl Cyclase/CD38 Gene Family in Physiology and Pathology
Physiol Rev, July 1, 2008; 88(3): 841 - 886.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. C. Rodriguez-Alba, M. E. Moreno-Garcia, C. Sandoval-Montes, V. H. Rosales-Garcia, and L. Santos-Argumedo
CD38 induces differentiation of immature transitional 2 B lymphocytes in the spleen
Blood, April 1, 2008; 111(7): 3644 - 3652.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Gallay, L. Anani, A. Lopez, P. Colombat, C. Binet, J. Domenech, B. B. Weksler, F. Malavasi, and O. Herault
The Role of Platelet/Endothelial Cell Adhesion Molecule 1 (CD31) and CD38 Antigens in Marrow Microenvironmental Retention of Acute Myelogenous Leukemia Cells
Cancer Res., September 15, 2007; 67(18): 8624 - 8632.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. D. Joshi, G. V. Hegde, J. D. Dickinson, A. K. Mittal, J. C. Lynch, J. D. Eudy, J. O. Armitage, P. J. Bierman, R. G. Bociek, M. P. Devetten, et al.
ATM, CTLA4, MNDA, and HEM1 in High versus Low CD38 Expressing B-Cell Chronic Lymphocytic Leukemia
Clin. Cancer Res., September 15, 2007; 13(18): 5295 - 5304.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Deaglio, T. Vaisitti, S. Aydin, E. Ferrero, and F. Malavasi
In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia
Blood, August 15, 2006; 108(4): 1135 - 1144.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
F. E. Lund, H. Muller-Steffner, H. Romero-Ramirez, M. E. Moreno-Garcia, S. Partida-Sanchez, M. Makris, N. J. Oppenheimer, L. Santos-Argumedo, and F. Schuber
CD38 induces apoptosis of a murine pro-B leukemic cell line by a tyrosine kinase-dependent but ADP-ribosyl cyclase- and NAD glycohydrolase-independent mechanism
Int. Immunol., July 1, 2006; 18(7): 1029 - 1042.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Frasca, G. Fedele, S. Deaglio, C. Capuano, R. Palazzo, T. Vaisitti, F. Malavasi, and C. M. Ausiello
CD38 orchestrates migration, survival, and Th1 immune response of human mature dendritic cells
Blood, March 15, 2006; 107(6): 2392 - 2399.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M.-T. Zilber, N. Setterblad, T. Vasselon, C. Doliger, D. Charron, N. Mooney, and C. Gelin
MHC class II/CD38/CD9: a lipid-raft-dependent signaling complex in human monocytes
Blood, November 1, 2005; 106(9): 3074 - 3081.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Q. Chen and A. C. Ross
Inaugural Article: Vitamin A and immune function: Retinoic acid modulates population dynamics in antigen receptor and CD38-stimulated splenic B cells
PNAS, October 4, 2005; 102(40): 14142 - 14149.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Deaglio, T. Vaisitti, L. Bergui, L. Bonello, A. L. Horenstein, L. Tamagnone, L. Boumsell, and F. Malavasi
CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival
Blood, April 15, 2005; 105(8): 3042 - 3050.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. E. Moreno-Garcia, L. N. Lopez-Bojorques, A. Zentella, L. A. Humphries, D. J. Rawlings, and L. Santos-Argumedo
CD38 Signaling Regulates B Lymphocyte Activation via a Phospholipase C (PLC)-{gamma}2-Independent, Protein Kinase C, Phosphatidylcholine-PLC, and Phospholipase D-Dependent Signaling Cascade
J. Immunol., March 1, 2005; 174(5): 2687 - 2695.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
N. Chiorazzi, K. R. Rai, and M. Ferrarini
Chronic Lymphocytic Leukemia
N. Engl. J. Med., February 24, 2005; 352(8): 804 - 815.
[Full Text] [PDF]


Home page
BloodHome page
S. Deaglio, A. Capobianco, L. Bergui, J. Durig, F. Morabito, U. Duhrsen, and F. Malavasi
CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells
Blood, September 15, 2003; 102(6): 2146 - 2155.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Chen, G. Widhopf, L. Huynh, L. Rassenti, K. R. Rai, A. Weiss, and T. J. Kipps
Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia
Blood, December 15, 2002; 100(13): 4609 - 4614.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Deaglio, M. Zubiaur, A. Gregorini, F. Bottarel, C. M. Ausiello, U. Dianzani, J. Sancho, and F. Malavasi
Human CD38 and CD16 are functionally dependent and physically associated in natural killer cells
Blood, April 1, 2002; 99(7): 2490 - 2498.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Ibrahim, M. Keating, K.-A. Do, S. O'Brien, Y. O. Huh, I. Jilani, S. Lerner, H. M. Kantarjian, and M. Albitar
CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia
Blood, July 1, 2001; 98(1): 181 - 186.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
R. Mallone, A. Funaro, M. Zubiaur, G. Baj, C. M. Ausiello, C. Tacchetti, J. Sancho, C. Grossi, and F. Malavasi
Signaling through CD38 induces NK cell activation
Int. Immunol., April 1, 2001; 13(4): 397 - 409.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. J. Guilliano, A. E. Foxx-Orenstein, and D. A. Lebman
The Microenvironment of Human Peyer's Patches Inhibits the Increase in CD38 Expression Associated with the Germinal Center Reaction
J. Immunol., February 15, 2001; 166(4): 2179 - 2185.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Zupo, R. Massara, M. Dono, E. Rossi, F. Malavasi, M. E. Cosulich, and M. Ferrarini
Apoptosis or plasma cell differentiation of CD38-positive B-chronic lymphocytic leukemia cells induced by cross-linking of surface IgM or IgD
Blood, February 15, 2000; 95(4): 1199 - 1206.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
D. R. Karp, M. L. Carlisle, A. B. Mobley, T. C. Nichols, N. Oppenheimer-Marks, R. I. Brezinschek, and V. M. Holers
{gamma}-Glutamyl transpeptidase is up-regulated on memory T lymphocytes
Int. Immunol., November 1, 1999; 11(11): 1791 - 1800.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Zubiaur, M. Guirado, C. Terhorst, F. Malavasi, and J. Sancho
The CD3-gamma delta epsilon Transducing Module Mediates CD38-induced Protein-tyrosine Kinase and Mitogen-activated Protein Kinase Activation in Jurkat T Cells
J. Biol. Chem., July 16, 1999; 274(29): 20633 - 20642.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
T. Yasue, M. Baba, S. Mori, C. Mizoguchi, S. Uehara, and K. Takatsu
IgG1 production by sIgD+ splenic B cells and peritoneal B-1 cells in response to IL-5 and CD38 ligation
Int. Immunol., June 1, 1999; 11(6): 915 - 923.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. E. Lund, H. M. Muller-Steffner, N. Yu, C. D. Stout, F. Schuber, and M. C. Howard
CD38 Signaling in B Lymphocytes Is Controlled by Its Ectodomain but Occurs Independently of Enzymatically Generated ADP-Ribose or Cyclic ADP-Ribose
J. Immunol., March 1, 1999; 162(5): 2693 - 2702.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Kitanaka, T. Suzuki, C. Ito, H. Nishigaki, E. Coustan-Smith, T. Tanaka, Y. Kubota, and D. Campana
CD38-Mediated Signaling Events in Murine Pro-B Cells Expressing Human CD38 With or Without Its Cytoplasmic Domain
J. Immunol., February 15, 1999; 162(4): 1952 - 1958.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Itoh, K. Ishihara, T. Hiroi, B. Ok Lee, H. Maeda, H. Iijima, M. Yanagita, H. Kiyono, and T. Hirano
Deletion of Bone Marrow Stromal Cell Antigen-1 (CD157) Gene Impaired Systemic Thymus Independent-2 Antigen-Induced IgG3 and Mucosal TD Antigen-Elicited IgA Responses
J. Immunol., October 15, 1998; 161(8): 3974 - 3983.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. A. Cockayne, T. Muchamuel, J. C. Grimaldi, H. Muller-Steffner, T. D. Randall, F. E. Lund, R. Murray, F. Schuber, and M. C. Howard
Mice Deficient for the Ecto-Nicotinamide Adenine Dinucleotide Glycohydrolase CD38 Exhibit Altered Humoral Immune Responses
Blood, August 15, 1998; 92(4): 1324 - 1333.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
V. W.F. Chan, I. Mecklenbrauker, I-h. Su, G. Texido, M. Leitges, R. Carsetti, C. A. Lowell, K. Rajewsky, K. Miyake, and A. Tarakhovsky
The Molecular Mechanism of B Cell Activation by toll-like Receptor Protein RP-105
J. Exp. Med., July 1, 1998; 188(1): 93 - 101.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Ridderstad and D. M. Tarlinton
Kinetics of Establishing the Memory B Cell Population as Revealed by CD38 Expression
J. Immunol., May 15, 1998; 160(10): 4688 - 4695.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. Morra, M. Zubiaur, C. Terhorst, J. Sancho, and F. Malavasi
CD38 is functionally dependent on the TCR/CD3 complex in human T cells
FASEB J, May 1, 1998; 12(7): 581 - 592.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
A. Cesano, S. Visonneau, S. Deaglio, F. Malavasi, and D. Santoli
Role of CD38 and Its Ligand in the Regulation of MHC-Nonrestricted Cytotoxic T Cells
J. Immunol., February 1, 1998; 160(3): 1106 - 1115.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Deaglio, M. Morra, R. Mallone, C. M. Ausiello, E. Prager, G. Garbarino, U. Dianzani, H. Stockinger, and F. Malavasi
Human CD38 (ADP-Ribosyl Cyclase) Is a Counter-Receptor of CD31, an Ig Superfamily Member
J. Immunol., January 1, 1998; 160(1): 395 - 402.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. B. Satterthwaite, H. Cheroutre, W. N. Khan, P. Sideras, and O. N. Witte
Btk dosage determines sensitivity to B cell antigen receptor cross-linking
PNAS, November 25, 1997; 94(24): 13152 - 13157.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.